| Name | Valley Inn, The |
|---|---|
| Location | 211 3rd Ave, Mancos, Colorado |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 89.83% |
| Medicare ID (CCN) | 065306 |
| Legal Business Name | Animas Equity, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1467189100 |
| Organization Name | THE VALLEY REHABILITATION AND HEALTHCARE CENTER LLC |
| Address | 211 E 3rd Ave, Mancos, CO 81328 |
| Phone Number | 970-533-9031 |
News Archive
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for its third quarter ended September 30, 2009.
New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.
50 years of pioneering asthma research which has benefited patients and sufferers throughout the UK will be celebrated at an event hosted by the University of Leicester on Wednesday 20 June.
Vaccines have a long history of successfully preventing disease and, in effect, improving the lives of countless Americans. Now, two serious diseases - human papillomavirus (HPV) and herpes zoster - could become a thing of the past as people better understand the safety and efficacy of vaccines to prevent these serious viral infections in specific populations.
› Verified 4 days ago
| NPI Number | 1639177801 |
| Organization Name | ANIMAS EQUITY, INC. |
| Doing Business As | THE VALLEY INN |
| Address | 211 E 3rd Ave, Mancos, CO 81328 |
| Phone Number | 970-533-9031 |
News Archive
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for its third quarter ended September 30, 2009.
New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.
50 years of pioneering asthma research which has benefited patients and sufferers throughout the UK will be celebrated at an event hosted by the University of Leicester on Wednesday 20 June.
Vaccines have a long history of successfully preventing disease and, in effect, improving the lives of countless Americans. Now, two serious diseases - human papillomavirus (HPV) and herpes zoster - could become a thing of the past as people better understand the safety and efficacy of vaccines to prevent these serious viral infections in specific populations.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for its third quarter ended September 30, 2009.
New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.
50 years of pioneering asthma research which has benefited patients and sufferers throughout the UK will be celebrated at an event hosted by the University of Leicester on Wednesday 20 June.
Vaccines have a long history of successfully preventing disease and, in effect, improving the lives of countless Americans. Now, two serious diseases - human papillomavirus (HPV) and herpes zoster - could become a thing of the past as people better understand the safety and efficacy of vaccines to prevent these serious viral infections in specific populations.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7699 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.15 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.63 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.53 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.3 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.86 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.91 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 2.86 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.43 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 19.52 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |